Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03332498 |
|---|---|
| Brief Title: | Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers |
| First Submitted : | November 2, 2017 |
| First Submitted that Met QC Criteria : | November 2, 2017 |
| First Posted : | November 6, 2017 |
| Results First Submitted : | December 4, 2020 |
| Results First Posted with QC Comments : | December 30, 2020 |
| Results First Submitted that Met QC Criteria : | December 29, 2020 |
| Results First Posted : | January 22, 2021 |
| Last Update Submitted that Met QC Criteria : | June 1, 2022 |
| Last Update Posted : | June 3, 2022 |